Swedish Cancer Institute to Strengthen Delivery of Precision Medicine in Breast Cancer Care | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Swedish Cancer Institute to Strengthen Delivery of Precision Medicine in Breast Cancer Care

September 15, 2017
by Rajiv Leventhal
| Reprints

The Seattle-based Swedish Cancer Institute (SCI) and precision medicine company GNS Healthcare have announced a machine learning collaboration with the aim to strengthen, accelerate, and potentially expand the delivery of precision medicine in breast cancer care.

GNS Healthcare’s machine learning and simulation platform, REFS (Reverse Engineering and Forward Simulation), will be employed to build computer models and ultimately a software interface tool that will link clinical and molecular data to treatment and outcomes across SCI's patient population, officials attest.

What’s more, the collaboration will use aggregated patient data from SCI's breast cancer research registry, and personalized medicine research program (PMRP), to build these computer models. REFS-generated models can support clinical decision-making through a better understanding of treatment success based on individualized genetic backgrounds. As such, these models can be used to simulate potential treatment interventions and their effect on disease outcomes. The results of these analyses can then be interpreted through GNS's software interface to support the optimal delivery of treatments to individual patients, according to officials.

Henry Kaplan, M.D., head of breast medical oncology, and principal investigator of the breast cancer research registry, emphasized that "this project has the potential to optimize use of genomic information in the care of our breast cancer patients, to include through our SCI Molecular Tumor Board."

Indeed, by automating the process of connecting cancer patients with their most effective treatment, the GNS-SCI collaboration demonstrates a framework for scaling precision medicine initiatives. The approach makes it possible to generate the data needed by healthcare payers to prove the value of precision medicine, an outcome that would bring clarity to reimbursement decisions and expand access to life-saving treatments and better outcomes for patients, officials note.

“Few oncologists today have the complete training or time necessary to decipher complex results of a tumor's biologic fingerprint. GNS' REFS-generated models will streamline this process and enhance our PMRP's work to support providers and their patients with treatment recommendations," Thomas Brown, M.D., executive director of the Swedish Cancer Institute, said in a prepared statement. "This unique collaboration is intended to facilitate the practice of personalized, i.e. precision, medicine at the SCI, increasing access of this important resource to our patients, while allowing our doctors to remain patient-focused."

Get the latest information on Health IT and attend other valuable sessions at this two-day Summit providing healthcare leaders with educational content, insightful debate and dialogue on the future of healthcare and technology.

Learn More

Topics

News

Healthcare Execs Anticipate High Cost Returns from Predictive Analytics Use

Healthcare executives are dedicating budget to predictive analytics, and are forecasting significant cost savings in return, according to new research from the Illinois-based Society of Actuaries.

Adam Boehler Tapped by Azar to Serve as Senior Value-Based Care Advisor

Adam Boehler, currently director of CMMI, has also been named the senior advisor for value-based transformation and innovation, HHS Secretary Alex Azar announced.

Vivli Launches Clinical Research Data-Sharing Platform

On July 19 a new global data-sharing and analytics platform called Vivli was unveiled. The nonprofit group’s mission is to promote, coordinate and facilitate scientific sharing and reuse of clinical research data.

Survey: More Effective IT Needed to Improve Patient Safety

In a Health Catalyst survey, physicians, nurses and healthcare executives said ineffective information technology, and the lack of real-time warnings for possible harm events, are key obstacles to achieving their organizations' patient safety goals.

Physicians Still Reluctant to Embrace Virtual Tech, Survey Finds

While consumers and physicians agree that virtual healthcare holds great promise for transforming care delivery, physicians still remain reluctant to embrace the technologies, according to a new Deloitte Center for Health Solutions survey.

Geisinger, AstraZeneca Partner on Asthma App Suite

Geisinger has partnered with pharmaceutical company AstraZeneca to create a suite of products that integrate into the electronic health record and engage asthma patients and their providers in co-managing the disease.